TransSerum® FQ Fetal Bovine Serum

胎牛血清 FQ

目录号 规格 单价
FS301-02 500 ml 4800
说明书
质检报告
立即下单
加入购物车

产品详情介绍

本产品以健康胎牛血液为原料加工而成,经3次0.1 μm微孔滤膜过滤,无支原体污染,不含BVDV、BPV等牛源病毒,内毒素水平极低。培养细胞种类多,细胞生长速度快,状态好,适用于间充质干细胞的培养。培养的细胞适用于多种下游实验。


产品组成

实验数据

【广谱通用型】“够用不贵”的性价比典范,为多种常见传代细胞系提供稳定可靠的支持。


应用范围:适用于间充质干细胞及常见传代细胞如A549、HeLa、Vero、MDCK等多种细胞的培养。


TransSerum® FQ Fetal Bovine Serum成功培养的细胞

image.png

稳定性好

image.png

病毒检测

image.png

支原体检测

image.png


间充质干细胞培养图

image.png


普通细胞培养图 (部分结果)

image.png



image.png

image.png

血清介绍视频

References
  • Xu Y, Chen J, Liu Y, et al. The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice[J]. European Heart Journal, 2025.(IF 35.60)

  • Chen K, Liu S, Lv L, et al. Well-established immunotherapy with R837-loaded boron neutron capture-shocked tumor cells[J]. Nano Today, 2023.(IF 17.40)

  • Qin P P, Chen P R, Tan L, et al. Programming ADAR-recruiting hairpin RNA sensor to detect endogenous molecules[J]. Nucleic Acids Research, 2025.(IF 16.70)

  • Chen P R, Qin P P, Wang Y N, et al. De novo design of hypercompact transcript degraders by engineering substrate-specific toxins and Cas6-CBS system[J]. Nature Communications, 2025.(IF 15.70)

  • Hou P, Zhu H, Chu F, et al. Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB[J]. Nature Communications, 2025.(IF 15.70)

  • Liang H, Chen K, Xie J, et al. A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication[J]. Small, 2023.(IF 15.15)

  • Huang T, Wang Z, Gao L, et al. Targeting adipocyte ESRRA alleviates osteoarthritis via interrupting inter-organelle crosstalk of complement C3-CFD-MAC cascade: Targeting ESRRA-mediated complement cascade alleviates OA[J]. Bone Research, 2026.(IF 15.00)

  • Gao J, Yang M, Duan R, et al. Hepatocyte estrogen-related receptor α modulates a gluconeogenic–epigenetic crosstalk counteracting MASLD/MASH progression[J]. Experimental & Molecular Medicine, 2026.(IF 12.90)

说明书下载

质检报告

登录

captcha

注册

*收货地址:
captcha

客服

微信